Quickstart Highlights
BPC-157 (Body Protection Compound-157) is a synthetic peptide composed of 15 amino acids, derived from a gastric protein sequence and investigated for tissue-healing and cytoprotective effects. Preclinical research demonstrates accelerated wound repair and anti-inflammatory activity, while human clinical evidence is currently limited to early-phase safety studies and small case reports. This educational protocol outlines a once-daily subcutaneous approach using a practical dilution to enable clear and accurate insulin-syringe measurements.
- Reconstitute: Add 3.0 mL bacteriostatic water → 1.67 mg/mL concentration.
- Typical daily range: 200–600 mcg once daily (gradual titration).
- Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg on a U-100 insulin syringe.
- Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
Dosing & Reconstitution Guide
Educational guide for reconstitution and daily dosing
Standard / Gradual Approach (3 mL = ~ 1.67 mg/mL)
Route: Subcutaneous | Frequency: Once daily
| WEEK |
Daily Dose (MCG) |
UNITS (PER INJECTION) (ML) |
| Weeks 1–2 |
200 mcg (0.2 mg) |
12 units (0.12 mL) |
| Weeks 3–4 |
400 mcg (0.4 mg) |
24 units (0.24 mL) |
| Weeks 5–8+ |
600 mcg (0.6 mg) |
36 units (0.36 mL) |
Frequency: Inject once daily subcutaneously. This schedule uses the largest practical dilution (3.0 mL) to keep per-injection units well above 10 for better accuracy. Dosing is extrapolated from preclinical models; human clinical validation remains limited.
Reconstitution Steps
- Draw 3.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake).
- Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Supplies Needed
Plan based on an 8–16 week daily protocol with gradual titration.
- Peptide Vials (BPC-157, 5 mg each):
- 8 weeks ≈ 6 vials (25.2 mg used)
- 12 weeks ≈ 9 vials (42 mg used)
- 16 weeks ≈ 12 vials (58.8 mg used)
- Insulin Syringes (U-100):
- Per week: 7 syringes (1/day)
- 8 weeks: 56 syringes
- 12 weeks: 84 syringes
- 16 weeks: 112 syringes
- Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
- 8 weeks (6 vials): 18 mL → 2 × 10 mL bottles
- 12 weeks (9 vials): 27 mL → 3 × 10 mL bottles
- 16 weeks (12 vials): 36 mL → 4 × 10 mL bottles
- Alcohol Swabs: One for the vial stopper + one for the injection site each day.
- Per week: 14 swabs (2/day)
- 8 weeks: 112 swabs → recommend 2 × 100-count boxes
- 12 weeks: 168 swabs → recommend 2 × 100-count boxes
- 16 weeks: 224 swabs → recommend 3 × 100-count boxes
Protocol Overview
Brief outline of the once-daily regimen.
- Goal: Promote tissue repair and recovery based on findings from preclinical research.
- Schedule: Administer subcutaneous injections daily for 8–12 weeks (may be extended to 16 weeks if needed).
- Dose Range: 200–600 mcg per day with slow, stepwise titration.
- Reconstitution: Dilute each 5 mg vial with 3.0 mL to achieve an approximate concentration of 1.67 mg/mL for precise unit dosing.
- Storage: Keep lyophilized material frozen; after reconstitution, store under refrigeration and avoid repeated freeze–thaw cycles.
Dosing Protocol
Suggested daily titration approach.
-
- Start: 200 mcg daily; increase by ~200 mcg every 2 weeks as tolerated.
- Target: 400–600 mcg daily by Weeks 5–8+.
- Frequency: Once per day (subcutaneous).
- Cycle Length: 8–12 weeks; optional extension to 16 weeks.
- Timing: Any consistent time; rotate injection sites.
Storage Instructions
Proper storage helps maintain peptide quality.
- Lyophilized: Store at −20 °C (−4 °F) in a dry, dark environment and limit exposure to moisture.
- Reconstituted: Keep refrigerated at 2–8 °C (35.6–46.4 °F); use within 28 days and do not freeze the liquid solution.
- Allow vials to reach room temperature before opening to minimize condensation absorption.
Important Notes
Practical considerations for consistency and safety.
- Use a new sterile insulin syringe for each injection and dispose of it in a sharps container.
- Rotate injection sites (abdomen, thighs, upper arms) to minimize local irritation.
- Inject slowly and pause for a few seconds before withdrawing the needle.
- Record the daily dose and injection site rotation to ensure consistency.
- Human data on BPC-157 are preliminary; clinical decisions should involve qualified healthcare providers.
How it works
BPC-157 is a synthetic peptide that corresponds to a partial sequence of a human gastric juice protein. Preclinical research suggests it influences nitric oxide signaling and growth-factor expression, supporting angiogenesis and collagen formation in injured tissues. Animal models have demonstrated accelerated healing of gut, tendon, ligament, and muscle injuries. A Phase I oral safety study has been completed, and a small human case series reported improvements following intra-articular administration; however, large-scale, controlled human efficacy data are not yet available.
Potential Benefits & Side Effects
Observations from preclinical and early clinical literature.
- Supports tissue repair in gut, tendon, muscle, and skin injury models (animal data).
- Demonstrates anti-inflammatory and cytoprotective effects in preclinical settings.
- Phase I safety studies indicate good tolerability with no serious adverse events at evaluated doses.
- Occasional mild injection-site reactions (redness, itching) may occur with subcutaneous use.
- Long-term human safety and efficacy are still under investigation.
Lifestyle Factors
Complementary strategies for best outcomes.
- Support recovery through sufficient protein intake and micronutrient-dense foods.
- Balance physical activity with adequate rest to enable tissue adaptation without overuse.
- Prioritize quality sleep and stress management to support natural healing processes.
- Consult qualified healthcare providers for injury-specific rehabilitation guidance.
Injection Technique
General subcutaneous guidance from clinical best-practice resources.
- Clean the vial stopper and skin with alcohol; allow to dry.
- Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue.
- Do not aspirate for subcutaneous injections; inject slowly and steadily.
- Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.
- Discard used syringes immediately in a sharps container per WHO guidelines.
Recommended Source
We recommend Ion Peptide for high-purity BPC-157 (5 mg).
Why Ion Peptide?
- High-purity, third-party-tested lots with batch COAs.
- Consistent, ISO-aligned handling and documentation.
- Reliable fulfillment to maintain cold-chain integrity.
Shop at Ion Peptide
Important Note
This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment. BPC-157 remains investigational with limited human clinical data.
